Alseres Pharmaceuticals, Inc.
ALSE · OTC
12/31/2013 | 12/31/2012 | 12/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$942 | -$1,645 | $0 | $512 |
| Dep. & Amort. | $1 | $1 | $41 | $59 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,293 | $692 | $852 | $934 |
| Other Non-Cash | $546 | $0 | -$3,378 | -$4,456 |
| Operating Cash Flow | -$1,687 | -$952 | -$2,485 | -$2,951 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$2 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $884 | $0 | $0 | $35 |
| Other Inv. Act. | $884 | $0 | $304 | $0 |
| Investing Cash Flow | $884 | $0 | $301 | $35 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $725 | $510 | $2,239 | $2,707 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$2 | -$18 | -$8 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $175 | $325 | $0 | $0 |
| Financing Cash Flow | $900 | $833 | $2,221 | $2,699 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $97 | -$119 | $37 | -$216 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17 | $136 | $99 | $315 |
| End Cash | $114 | $17 | $136 | $99 |
| Free Cash Flow | -$1,687 | -$952 | -$2,487 | -$2,951 |